Psyence Biomedical (PBM) Payables (2023 - 2025)

Psyence Biomedical (PBM) recorded quarterly Payables of $261937.0 in Q1 2025, down 53.42% quarter-over-quarter from $562352.0 in Q1 2024, and down 53.42% on a YoY basis from $562352.0 in Q1 2024.

Psyence Biomedical (PBM) Payables (2023 - 2025) Analysis & Trends

Psyence Biomedical's Payables history runs 3 years deep, the most recent figure standing at $261937.0 for Q1 2025.

  • In Q1 2025, Payables fell 53.42% year-over-year to $261937.0; the TTM figure through Mar 2025 stood at $261937.0 (down 53.42% YoY), while the FY2025 annual figure was $261937.0, down 53.42% from the prior year.
  • Payables was $261937.0 for Q1 2025 at Psyence Biomedical, down from $562352.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $1.8 million in Q1 2023 to a low of $261937.0 in Q1 2025.
  • Historically, Payables has averaged $871663.0 across 3 years, with a median of $562352.0 in 2024.
  • The sharpest annual moves came in 2024 and 2025: Payables sank 68.6% in 2024, then slumped 53.42% in 2025.
  • A 3-year view of Payables shows it stood at $1.8 million in 2023, then tumbled by 68.6% to $562352.0 in 2024, then plunged by 53.42% to $261937.0 in 2025.
  • The last three Payables figures came in at $261937.0 (Q1 2025), $562352.0 (Q1 2024), and $1.8 million (Q1 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 1.05 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 300,549.00
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 83.00 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 8.69 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 489.30 Mn
9 Abivax 94.26 Bn 94.26 Bn - 34.55 Mn
10 Regeneron Pharmaceuticals 66.09 Bn 57.33 Bn 3.31 Bn 1.03 Bn

Historic Data

Download Data
DateValue
Mar 31, 2025 261,937.00
Mar 31, 2024 562,352.00
Mar 31, 2023 1.79 Mn